Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis

Autotaxin (ATX) is considered as an interesting drug target for the therapy of several diseases. The goal of the research was to detect new ATX inhibitors which have novel scaffolds by using virtual screening. First, based on two diverse receptor-ligand complexes, 14 pharmacophore models were develo...

Full description

Bibliographic Details
Main Authors: Ji-Xia Ren, Rui-Tao Zhang, Hui Zhang
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/5/1107
_version_ 1819266360625070080
author Ji-Xia Ren
Rui-Tao Zhang
Hui Zhang
author_facet Ji-Xia Ren
Rui-Tao Zhang
Hui Zhang
author_sort Ji-Xia Ren
collection DOAJ
description Autotaxin (ATX) is considered as an interesting drug target for the therapy of several diseases. The goal of the research was to detect new ATX inhibitors which have novel scaffolds by using virtual screening. First, based on two diverse receptor-ligand complexes, 14 pharmacophore models were developed, and the 14 models were verified through a big test database. Those pharmacophore models were utilized to accomplish virtual screening. Next, for the purpose of predicting the probable binding poses of compounds and then carrying out further virtual screening, docking-based virtual screening was performed. Moreover, an excellent 3D QSAR model was established, and 3D QSAR-based virtual screening was applied for predicting the activity values of compounds which got through the above two-round screenings. A correlation coefficient r<sup>2</sup>, which equals 0.988, was supplied by the 3D QSAR model for the training set, and the correlation coefficient r<sup>2</sup> equaling 0.808 for the test set means that the developed 3D QSAR model is an excellent model. After the filtering was done by the combinatory virtual screening, which is based on the pharmacophore modelling, docking study, and 3D QSAR modelling, we chose nine potent inhibitors with novel scaffolds finally. Furthermore, two potent compounds have been particularly discussed.
first_indexed 2024-12-23T21:00:02Z
format Article
id doaj.art-91a4f711e1004355a89212699cc38107
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-23T21:00:02Z
publishDate 2020-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-91a4f711e1004355a89212699cc381072022-12-21T17:31:24ZengMDPI AGMolecules1420-30492020-03-01255110710.3390/molecules25051107molecules25051107Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR AnalysisJi-Xia Ren0Rui-Tao Zhang1Hui Zhang2College of Life Science, Liaocheng University, Liaocheng 252059, ChinaCollege of Agronomy, Liaocheng University, Liaocheng 252059, ChinaCollege of Life Science, Northwest Normal University, Lanzhou 730070, ChinaAutotaxin (ATX) is considered as an interesting drug target for the therapy of several diseases. The goal of the research was to detect new ATX inhibitors which have novel scaffolds by using virtual screening. First, based on two diverse receptor-ligand complexes, 14 pharmacophore models were developed, and the 14 models were verified through a big test database. Those pharmacophore models were utilized to accomplish virtual screening. Next, for the purpose of predicting the probable binding poses of compounds and then carrying out further virtual screening, docking-based virtual screening was performed. Moreover, an excellent 3D QSAR model was established, and 3D QSAR-based virtual screening was applied for predicting the activity values of compounds which got through the above two-round screenings. A correlation coefficient r<sup>2</sup>, which equals 0.988, was supplied by the 3D QSAR model for the training set, and the correlation coefficient r<sup>2</sup> equaling 0.808 for the test set means that the developed 3D QSAR model is an excellent model. After the filtering was done by the combinatory virtual screening, which is based on the pharmacophore modelling, docking study, and 3D QSAR modelling, we chose nine potent inhibitors with novel scaffolds finally. Furthermore, two potent compounds have been particularly discussed.https://www.mdpi.com/1420-3049/25/5/1107autotaxin inhibitor3d qsar modelpharmacophore modelvirtual screeningdocking calculation
spellingShingle Ji-Xia Ren
Rui-Tao Zhang
Hui Zhang
Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
Molecules
autotaxin inhibitor
3d qsar model
pharmacophore model
virtual screening
docking calculation
title Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
title_full Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
title_fullStr Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
title_full_unstemmed Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
title_short Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
title_sort identifying novel atx inhibitors via combinatory virtual screening using crystallography derived pharmacophore modelling docking study and qsar analysis
topic autotaxin inhibitor
3d qsar model
pharmacophore model
virtual screening
docking calculation
url https://www.mdpi.com/1420-3049/25/5/1107
work_keys_str_mv AT jixiaren identifyingnovelatxinhibitorsviacombinatoryvirtualscreeningusingcrystallographyderivedpharmacophoremodellingdockingstudyandqsaranalysis
AT ruitaozhang identifyingnovelatxinhibitorsviacombinatoryvirtualscreeningusingcrystallographyderivedpharmacophoremodellingdockingstudyandqsaranalysis
AT huizhang identifyingnovelatxinhibitorsviacombinatoryvirtualscreeningusingcrystallographyderivedpharmacophoremodellingdockingstudyandqsaranalysis